During the past decade, Clinique specialisee en allergie de la capitale conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique specialisee en allergie de la capitale" #1 sponsor was "Shire" with 5 trials, followed by "DBV Technologies" with 3 trials sponsored, "ALK-Abelló A/S" with 2 trials sponsored, "Circassia Limited" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique specialisee en allergie de la capitale" #1 collaborator was "Adiga Life Sciences, Inc." with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "ALK-Abelló A/S" with 1 trials as a collaborator and "Atlantic Research Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clinique specialisee en allergie de la capitale" are "Allergy" (3 trials), "Hereditary Angioedema (HAE)" (3 trials), "Asthma" (2 trials), "Hereditary Angioedema" (2 trials) and "Peanut Allergy" (2 trials). Many other conditions were trialed in "Clinique specialisee en allergie de la capitale" in a lesser frequency.

Most popular intervention types in "Clinique specialisee en allergie de la capitale" are "Drug" (11 trials), "Biological" (10 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Viaskin Peanut 250 mcg" (2 trials), "Viaskin Placebo" (2 trials), "BLU-5937" (1 trials) and "CSL312" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique specialisee en allergie de la capitale" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Clinique specialisee en allergie de la capitale". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Clinique specialisee en allergie de la capitale, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique specialisee en allergie de la capitale, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".